Cite
HARVARD Citation
Vaishampayan, U. et al. (n.d.). 2022-RA-588-ESGO Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients with advanced solid tumours: ARTISTRY-1. International journal of gynecological cancer. p. A241. [Online].